nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Ambulatory oxygen and quality of life in interstitial lung disease
|
Page, David B |
|
2018 |
6 |
10 |
p. 730-731 |
artikel |
2 |
Black lung is still a threat
|
Morgan, Jules |
|
2018 |
6 |
10 |
p. 745-746 |
artikel |
3 |
Changing the treatment landscape for latent tuberculosis with rifampicin
|
Venkatesan, Priya |
|
2018 |
6 |
10 |
p. 740 |
artikel |
4 |
Corrections
|
|
|
2018 |
6 |
10 |
p. e53 |
artikel |
5 |
Corrections
|
|
|
2018 |
6 |
10 |
p. e53 |
artikel |
6 |
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
|
Visca, Dina |
|
2018 |
6 |
10 |
p. 759-770 |
artikel |
7 |
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
|
Duruisseaux, Michäel |
|
2018 |
6 |
10 |
p. 771-781 |
artikel |
8 |
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study
|
Schauwvlieghe, Alexander F A D |
|
2018 |
6 |
10 |
p. 782-792 |
artikel |
9 |
IPF diagnosis: flexibility is a virtue
|
Wells, Athol U |
|
2018 |
6 |
10 |
p. 735-737 |
artikel |
10 |
Let's add invasive aspergillosis to the list of influenza complications
|
Lamoth, Frederic |
|
2018 |
6 |
10 |
p. 733-735 |
artikel |
11 |
Negative trials in critical care medicine and the hurdles
|
Legrand, Matthieu |
|
2018 |
6 |
10 |
p. e53 |
artikel |
12 |
Peter Czanyo: lung cancer survivor
|
Reynoso, Cecilia |
|
2018 |
6 |
10 |
p. 746 |
artikel |
13 |
Predictive pathology of lung cancer immunotherapy response
|
Petersen, Iver |
|
2018 |
6 |
10 |
p. 731-733 |
artikel |
14 |
Six-lobe bronchoalveolar lavage in children with cystic fibrosis
|
Linnane, Barry |
|
2018 |
6 |
10 |
p. e51 |
artikel |
15 |
Six-lobe bronchoalveolar lavage in children with cystic fibrosis – Authors' reply
|
Forton, Julian T |
|
2018 |
6 |
10 |
p. e52 |
artikel |
16 |
Symptomatic COPD: is it time for triple therapy?
|
Bafadhel, Mona |
|
2018 |
6 |
10 |
p. 728-729 |
artikel |
17 |
Taking cystic fibrosis to the stage
|
Ranscombe, Peter |
|
2018 |
6 |
10 |
p. 743 |
artikel |
18 |
The long wait for lungs
|
The Lancet Respiratory Medicine, |
|
2018 |
6 |
10 |
p. 727 |
artikel |
19 |
The role of glucocorticoids as adjunctive treatment for sepsis in the modern era
|
Marik, Paul E |
|
2018 |
6 |
10 |
p. 793-800 |
artikel |
20 |
Tobacco control, lung cancer, and tuberculosis in Singapore
|
Furlow, Bryant |
|
2018 |
6 |
10 |
p. 741-742 |
artikel |
21 |
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial
|
Ferguson, Gary T |
|
2018 |
6 |
10 |
p. 747-758 |
artikel |
22 |
Tuberculosis incidence in England hits 30-year low
|
Kirby, Tony |
|
2018 |
6 |
10 |
p. 744 |
artikel |
23 |
Understanding irrationality: the key to changing behaviours and improving management of respiratory diseases?
|
Halpin, David M G |
|
2018 |
6 |
10 |
p. 737-739 |
artikel |